Vensana Capital
Minneapolis · Invests in Minneapolis, Minnesota, USA · Website
Check size
🔒 $•• – $••Thesis
Venture capital and growth equity firm dedicated exclusively to medtech, backing development- and commercial-stage companies. Covers medical devices, diagnostics and data science, drug delivery, digital health, life science tools and tech-enabled services.
Profile drafted from public signals. Our research team reviews every firm.
Partners & team
8 contacts on file
Vensana Capital in the news
FinSMEs
Apella Raises $80M in Series B Equity and Venture Debt
8 months ago
PR Newswire
Ventaris Surgical, Inc. Announces $30M Series A to Advance a Next-Generation System for Complete Kidney Stone Treatment
8 months ago
Failory
Top 6 Venture Capital Firms in Minneapolis (2026)
8 months ago
PR Newswire
Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth
9 months ago
Business Wire
Vensana Capital Launches Vensana Innovation and Adds Thomas Tu, MD, as Venture Partner
11 months ago
Med-Tech Insights
Luna Health raises $23.6M for automated insulin delivery solution
Aug 2025
citybiz
Vensana Capital Appoints Maria Berkman as Partner and Ross (Rusty) Segan as Venture Partner
Jun 2025
Business Wire
Vensana Capital Welcomes Maria Berkman as Partner and Ross (Rusty) Segan as Venture Partner
Jun 2025
MassDevice
Vensana Capital closes $425M raise for medtech investments
Jan 2025
Business Wire
Vensana Capital Closes $425 Million Fund III to Back Breakthrough Medical Technology Companies
Jan 2025
Star Tribune
Twin Cities venture firm raises another $425 million to fuel medtech companies
Jan 2025
Fierce Biotech
Vensana Capital keeps up momentum with third medtech investment fund, raising $425M
Jan 2025
The Business Journals
Vensana Capital closes on $425 million for newest fund
Jan 2025
BioSpace
Vensana Capital Closes $425 Million Fund III to Back Breakthrough Medical Technology Companies
Jan 2025
PR Newswire
Okami Medical Announces Closing Of $32.5M Financing
Oct 2024
citybiz.co
Vensana Capital Appoints Bill Hoffman as a Venture Partner
Jan 2024
Fierce Biotech
Vensana Capital redoubles medtech investment efforts with $325M 2nd fund
Sep 2021
tcbmag.com
Minneapolis-based Vensana Unveils $225 Million Venture Capital Fund
Sep 2019
WSJ
New Medtech Investor Vensana Closes $225 Million Debut Fund
Sep 2019
Fierce Biotech
Versant backs new, medtech-focused Vensana Capital fund, launching with $225M
Sep 2019
Add Vensana Capital to your investor list
Sign up free to save investors, see partner contacts, and track your raise.
Sign up